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INTRODUCTION AND BACKGROUND 
Euglycemia is the goal of therapy for diabetic patients receiving 
insulin or oral hypoglycemic medications. Without proper control of 
blood glucose concentration serious» complications may occur, such as, 
ketoacidosis or hypoglycemic shock. Historically, monitoring outpatient 
blood glucose has been accomplished by measuring the urine glucose 
content. Urine glucose indirectly reflects blood glucose concentration 
of 180 mg/dl or greater depending upon the glucose threshold of the 
* 
patient's kidneys, and is inadequate in detecting hypoglycemia (1). 
Until recently, directly measuring a patient's blood glucose concentra-
tion was a process requiring a clinical laboratory and a trained phlebo-
tomist to obtain blood for glucose analysis. With the advent of glucose 
reagent strips and reflectance photometers, home blood glucose moni-
toring has now become a possible alternative to urine glucose testing. 
Numerous reports and studies have defined the role of reagent strips and 
reflectance photometers in blood glucose monitoring procedures (2-25). 
The role of glucose monitoring is not limited to diabetic patients: 
hyperglycemia and hypoglycemia are metabolic problems frequently encoun-
tered in critical care medicine. Hypoglycemia can accompany endotoxin 
A list of all registered trade names utilized in this paper are 
listed in Tables 1 and 2. 
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shock, hemorrhagic shock, sepsis, pancreatitis, renal failure, alcohol-
ism, electrolyte and fluid therapy, hypothermia and the administration 
of numerous medications. Hyperglycemia, on the other hand, is fre-
quently observed in patients receiving dextrose solutions or medications 
which antagonize the action of insulin such as corticosteroids, glucagon 
and catecholamines. Other critically ill patients have pre-existing 
diabetes mellitus or develop clinical conditions which may result in 
hyperglycemia (7,8). Also in critical care medicine, diabetic ketoacid-
osis is a clinical disorder requiring knowledge of serial blood glucose 
concentrations for the adjustment of intravenous (I.V.) and subcutaneous 
insulin therapy. The frequency of altered glucose homeostasis in 
critically ill patients makes rapid, accurate and cost-effective deter-
mination of blood glucose concentration important. 
Another patient population which could benefit from such a blood 
glucose monitoring system are pregnant diabetics. The pregnant diabetic 
and her unborn child have an increased risk of morbidity from the 
effects of either hyperglycemia or hypoglycemia. The effect of hyper-
glycemia on fetal development includes excess fetal body fat, impaired 
pulmonary maturation, decreased serum potassium, muscle weakness, 
cardiac arrhythmias and death. Hypoglycemia has been associated with 
irreversible neurological damage (15). Maternal hyperglycemia had led 
to complications such as polyhydramnios, hypertension, urinary tract 
infection, candidal vaginitis, recurrent spontaneous abortions and 
infertility. The current recommendations for blood glucose monitoring 
in a pregnant diabetic requires seven daily blood glucose analyses 
(7,15,16). 
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In addition to the critically ill and the pregnant diabetic popula-
tions, all diabetic hospitalized patients could benefit from a system 
that would allow determination of blood glucose concentration prior to 
receiving their insulin dose, as opposed to an adjusted dose based upon 
laboratory information obtained several hours before dosing. 
Studies 
A number of studies have examined the accuracy of reflectance 
photometers and glucose reagent strips in comparison to hospital labora-
tory methods for blood glucose determination (2,3,6,8-14,16-20,22-25). 
Table 1 summarizes the brand name, manufacturer, chemical reagent system 
of the individual reagent strips and Table 2 presents a summary of the 
reflectance photometers used in the studies to be reviewed here. Table 
3 presents a summary of these studies. 
Stickland et al measured blood glucose concentrations in 171 
patients attending a diabetic outpatient clinic with both the Glucometer 
and Eyetone (in duplicate) and by the usual clinic method (Glucose 
Analyzer Model 23 am, Clandon Scientific, Trenton, NY). The correlation 
coefficient between blood glucose concentration using either Glucometer 
or Eyetone and the glucose analyzer was found to be r=0.981 with the 
Glucometer compared to r=0.968 for the Eyetone (no statistical compari-
son was reported). The authors found the Glucometer easier to use than 
the Eyetone in an outpatient clinic and it produced accurate and repro-
ducible results. Problems found with using the Glucometer by the 
medical staff included lengthy calibration procedures and a single 
occasion of malfunction (24). 
Chernow et al compared two reagent strips (Chemstrip BG and Dextro-
stix) for the quantitative estimation of whole blood glucose concentra-
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tions in 133 critically ill patients in an intensive care unit. Both 
strips were compared to the Roto Chem Parallel Fast Glucose Analyzer 
(Travenol Laboratories, Inc., Savage, MD) which served as the control. 
The authors found a significant correlation (r=0.95, p< 0.001) between 
both reagent strips and the measured values for the range of glucose 
concentration (10-600 mg/dl). In addition, the physicians found the 
Chemstrip BG easier to read and measured a wider range of glucose values 
than the Dextrostix method (8). 
Shapiro et al studied venous blood glucose concentrations deter-
mined by a hospital laboratory glucose analyzer (from Technicon SMAC) 
compared with concentrations of capillary blood glucose determined by 
# 
three reflectance photometers currently available in the United States 
(Eyetone, Dextrometer and Stat Tek) and by visual interpretation of 
reagent strips (Chemstrip BG). The authors found an acceptable correla-
tion between laboratory serum glucose concentration and reflectance 
photometer blood glucose determination (r=0.90-0.94) or visual interpre-
tation of Chemstrip BG (r=0.85-0.92) although statistical significance 
was not reported. The authors concluded that reagent strips not requir-
ing the use of a reflectance photometer provide a technique of home 
blood glucose monitoring similar in performance to those using reflec-
tance photometers. They also noted that although patients did not 
formally evaluate the three reflectance photometers, several patients 
expressed a preference for an instrument which provides an unequivocal 
reading of blood glucose concentration over a method requiring patient 
decision-making in the matching of reagent strips to a set of standard 
colors (19). 
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Schake et al examined the correlation between the blood glucose 
concentration estimated by diabetic patients at home using a Chemstrip 
BG reagent strip and blood glucose concentration subsequently measured 
by a Beckman Glucose Analyzer. The authors found a correlation (r=0.85, 
p < 0.001) between the blood glucose concentration as estimated by the 
Chemstrip BG and the blood glucose concentration as estimated by the 
Beckman Automated Glucose Analyzer 
The above studies indicate the utility of reflectance photometers 
and blood glucose reagent strips in monitoring blood glucose concentra-
tions. The use of a reflectance photometer with a glucose reagent strip 
may reduce the variability of results seen with the reagent strip alone. 
t> 
The measurement of blood glucose concentration using a reflectance 
photometer may be as accurate as a more sophisticated laboratory method. 
The present study was designed to compare the Chemstrip BG interpreted 
by the Accu-Chek reflectance photometer with the Beckman Astra 8 
Analyzer as a means of monitoring blood glucose concentrations in the 
hospital setting. 
STUDY OBJECTIVES 
1. To examine the correlation between Chemstrip BG reagent strips read 
by the Accu-Chek (reflectance photometer from Bio-Dynamics) as 
compared to the blood glucose concentration measured by the Beckman 
Astra 8 Analyzer as follows: 
a. Venous blood (Beckman) compared to venous blood (Accu-Chek) 
b. Venous blood (Beckman) compared to capillary blood (Accu-Chek) 
c. Venous blood (Accu-Chek) compared to capillary blood (Accu-
Chek) . 
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2. Compare the cost to the hospital of a laboratory blood glucose 
determination to the estimated cost of the Accu-Chek determination. 
MATERIALS AND METHODS 
Subjects 
Eighteen subjects who were inpatients in the University Hospital 
were admitted to the study after informed consent was obtained. This 
study was previously approved by the University of Utah Institutional 
Review Board. The study group was * composed of surgical and medical 
patients with the only exclusion criterion being hepatitis precautions 
or abnormal PTT, PT or bleeding time (normal limit as set by the clini-
cal laboratory at the University of Utah Hospital). The study popula-
tion consisted of ten female (ages 16-58 years) and eight male (ages 
23-61 years) patients. Six of these patients were diabetic. 
Blood Glucose Comparison 
A total of 50 venous blood samples and 50 capillary blood samples 
(obtained by finger puncture) was collected. These samples were then 
analyzed for blood glucose concentration using the Accu-Chek (reflec-
tance photometer) utilizing the Chemstrip BG reagent strip (both from 
Bio-Dynamics, Boehringer Mannhein Corporation, Indianapolis, IN 46250). 
The venous samples were also measured for plasma glucose concentration 
by the clinical laboratory associated with the University of Utah 
Hospital using the Beckman Astra 8 Analyzer, which was regarded as the 
reference (or true) value. The reported laboratory error of the Beckman 
Astra 8 analyzer at the University of Utah for plasma glucose concentra-
» 
tion determinations is 0.1%. 
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Blood Glucose Collection 
When the study patients were to have blood samples obtained for a 
laboratory blood glucose concentration determination, the phlebotomist 
obtained an additional small gray top tube (Vacutainer® , Bectin 
Dickinson, Rutherford, NJ) of blood (containing potassium oxalate and 
sodium fluoride), volume not exceeding one milliliter, for the Accu-Chek 
determination. Immediately following the venous blood collection 
(within five minutes) the patient underwent a finger (capillary) punc-
ture accomplished by an automatic blood letting device (Autoclix , 
Bio-Dynamics, Division of Boehringer Mannheim, Inc., Indianapolis, IN). 
Blood Glucose Determination 
The capillary blood sample (finger puncture) and the corresponding 
venous blood sample were measured for glucose concentration by the 
investigator using the Accu-Chek system. In all cases, the manufac-
turer's instructions pertaining to warm-up, calibration and operation of 
the reflectance photometer were adhered to strictly. 
Cost Analysis 
The second part of this study examined the cost difference of the 
two blood glucose monitoring systems. The cost of the hospital labora-
tory blood glucose concentration determination was compared with the 
estimated cost of the Accu-Chek determination. Included in the esti-
mated cost of the Accu-Chek determination are: 
1. The instrument cost distributed over one year. 
2. Material cost to include the Chemstrip BG, lancets, cotton balls 
and alcohol wipes. 
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3. Personnel cost based upon seven minutes (manufacturer's suggested 
test time) of an average hospital pharmacist's salary in Utah 
(approximately $25,000/year). 
The costs were taken as the retail selling price excluding discounts and 
rebates. 
Data Analysis 
The analysis of these types of data (predictions and reference or 
true values) has historically been linear regression analysis. In 1980 
Sheiner and Beal (26) suggested that computing the correlation coeffi-
cient and/or the regression of predictions on reference (true) values is 
only a poor description of predictive performance. The reason is the 
correlation coefficient measures the degree of association along the 
"best" line relating the two variables. When comparing precision or 
accuracy of a new diagnostic test against a reference standard, the 
degree of association along the line of identity (with a slope of one 
and a y-intercept of zero) must be determined. The best line is not 
necessarily the line of identity. Therefore, the analysis of the data 
included the mean squared prediction error (a descriptive measure of 
precision) (26). The student's t-test (two-tailed) for paired samples 
was used for statistical analysis of the differences between the 
reference value and the capillary and venous Accu-Chek values and 
between the Accu-Chek capillary and venous values. Statistical 
significance for the three blood glucose determinations was set at 
(p = 0.05). 
The mean, variance, range and standard deviation for both the error 
(difference in mg/dl from the true or reference value) and percent error 
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are reported. To coincide with the current medical literature, linear 
regression analysis comparing the laboratory blood glucose values vs the 
Accu-Chek capillary and venous values and comparing Accu-Chek venous vs 
Accu-Chek capillary values was performed and correlation coefficients 
(r) are reported. 
RESULTS 
The results of the 50 venous and capillary blood glucose determina-
tions by the Accu-Chek and the 50 venous blood glucose determinations by 
the clinical laboratory are listed in Table 4, 5, 6, and 7. These 
tables also provide the mean, variance, range and standard deviation of 
the error and percent error. The overall mean venous blood glucose 
concentration determination from the clinical laboratory was 115.9 mg/dl 
with a range of 58-282 mg/dl. The Accu-Chek system blood glucose 
concentration determination from the venous blood samples ranged from 
81-260 mg/dl with a mean value of 125.6 mg/dl, whereas the capillary 
blood samples ranged from 62-251 mg/dl with a mean value of 123.4 mg/dl. 
The Accu-Chek system reported a higher blood glucose concentration as 
compared to the clinical laboratory in 82% of the venous samples and in 
84% of the capillary samples. The overall percent error (difference) 
from the reference value (clinical laboratory value) and the capillary 
values (measured by the Accu-Chek system) was 11.8% as compared to 17.2% 
for the venous values (measured by the Accu-Chek system). The mean 
squared prediction error (precision) for the Accu-Chek capillary versus 
the laboratory method was 182.9 compared to 312.4 for the Accu-Chek 
venous method versus the laboratory method. 
A significant difference (p< 0.001) was found between the clinical 
laboratory and the Accu-Chek venous blood glucose concentration. 
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Likewise there was a statistically significant difference (p <0.001) 
between the Accu-Chek capillary blood glucose concentration and the 
clinical laboratory venous blood glucose concentration. There was no 
statistically significant difference between the Accu-Chek capillary and 
venous blood glucose concentrations. 
Linear regression analysis was applied to the data (Figures 1-3) 
which resulted in a correlation coefficient (r=0.99, p<0.001) comparing 
the Accu-Chek capillary blood glucose concentration with the clinical 
laboratory venous blood glucose concentration. A correlation (r=0.91, 
p < 0.001) was calculated between the Accu-Chek venous blood glucose 
concentration and the clinical laboratory venous blood glucose concen-
» 
tration. Finally a correlation coefficient (r=0.96, p < 0.001) between 
the Accu-Chek venous and Accu-Chek capillary blood glucose concen-
tration was performed. 
The cost analysis of the two glucose monitoring systems are sum-
marized in Table 8. 
DISCUSSION 
The study was undertaken to assess the feasibility of utilizing a 
reflectance photometer (Accu-Chek) as the primary instrument for blood 
glucose monitoring in the hospital setting. Blood glucose concentration 
assessment is a critical clinical analysis in the delivery of quality 
health care. Accuracy (performance) and cost are important factors that 
must be considered in the institution of a blood glucose monitoring 
system. However, at this time, there are no criteria for the degree of 
accuracy and precision of reflectance photometers. Without these 
criteria it is difficult to critically analyze the performance of the 
reflectance photometer. With the "normal" range of blood glucose 
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varying between 80-120 mg/dl, an acceptable degree of error will be 
difficult to determine. An error of 15% or less would likely not alter 
clinical decision-making. As the percent error increases so does the 
likelihood of an erroneous reading causing an unnecessary or detrimental 
change in therapy. In the present study, patients with plasma glucose 
concentrations exceeding 80 mg/dl had Accu-Chek capillary blood glucose 
readings within an acceptable deviation from the laboratory reading. 
As can be seen in Tables A, 5, and 6 the mean, variance, range and 
standard deviation of the percent error and error increase as the 
reported blood glucose concentrations decrease. The explanation for 
this phenomenon is not readily apparent. It is possibly an artifact of 
the sample size or perhaps an error in methodology. 
This study varied from the published literature in that the major-
ity of the Accu-Chek capillary blood glucose concentrations were found 
to be higher than those measured by the clinical laboratory. Arterial 
blood is generally higher in glucose content than venous blood (5,27, 
28) . The literature suggests that the finger pad or ear lobe (capil-
lary) blood glucose concentration approximates the glucose concentration 
of the arterial blood, and after eating, the arterial blood glucose 
concentrations usually range 20% to 30% higher than the venous blood 
(5,27,28). This study found that neither the venous nor capillary 
Accu-Chek blood glucose concentration was predominantly higher than the 
other. 
The analytical method employed by the clinical laboratory utilizes 
plasma rather than whole blood for glucose assay. It has been reported 
that the concentration of glucose in the plasma is 15% to 20% higher 
than the glucose concentration in whole blood. The present study found 
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a consistently higher glucose concentration in whole blood as measured 
by the Accu-Chek reflectance photometer. (5,27,28) This finding could 
result from a consistent error in methodology by the investigator or an 
error in the instrumentation. A measure of the inter-instrument reli-
ability of the Accu-Chek reflectance photometer should be determined to 
rule out instrument error. 
There was a lower mean squared error for the Accu-Chek capillary 
versus laboratory methods for measuring blood glucose compared to that 
for the Accu-Chek venous versus laboratory methods (182.9 and 312.4, 
respectively). These values indicate a greater precision and therefore 
a preference for using capillary blood rather than venous blood for the 
Accu-Chek method. 
In the cost analysis (Table 8) it was demonstrated that there is a 
potential for cost savings. At the University Hospital in 1984, 94 
diabetic patients were admitted for a variety of medical reasons with an 
average length of stay of 6.1 days. Assuming an average of three to 
four blood glucose determinations per day, the cost savings to the 
hospital would have been $135 to $185 per patient. With the implemen-
tation of prospective reimbursement programs for patient care the use of 
reflectance photometers for monitoring blood glucose concentrations may 
allow close patient monitoring while minimizing hospital costs. 
CONCLUSION 
This study demonstrates that the Accu-Chek reflectance photometer 
Is a clinically acceptable method for monitoring blood glucose concen-
trations in most hospitalized patients. Patients with blood glucose 
concentration readings below 80 mg/dl, however, may need to have their 
blood glucose concentration confirmed by a more precise method. Many 
hospitals and clinics throughout the country are currently using a 
reflectance photometer for their routine monitoring of blood glucose. 
The Accu-Chek was found to be a rapid, accurate and cost-effective 




Table 1. Blood Glucose Reagent Strips 
Product Manufacturer Range .(mg/dl) Chemical Reaction 
Chemstrip BG * Bio-Dynamics 40-80D Glucose oxidase/peroxidase 
Stat-Tek £ Bio-Dynamics - Glucose oxidase/peroxidase 
Dextrostix * * Ames 0-250 Glucose oxidase/peroxidase 
Visidex Ames** 20-800 Glucose oxidase/peroxidase 
* 
Bio-Dynamics, Division of Boehringer Mannheim, Inc., 
Indianapolis, IN. 
* * 
Ames, Division of Miles Laboratories, Inc., Elkhart, IN. 
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Table 2. Blood Glucose Reflectance Photometers 
Product Manufacturer Reagent Strip Used 
Dextrometer Ames * Dextrostix 
Glucometer Ames Dextrostix 
Glucoscan * Lifescan Dextrostix 
Accu-Chek Bio-Dynamics Chemstrip BG 
Eyetone Ames Dextrostix 
Stat Tek Bio-Dynamics Stat Tek 
* Lifescan, Sun Valley, CA. 
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Table 3. Literature Analysis 
Authors 
Method vs. 







Reeves (17 ) Chemstrip BG® 200 0.98 228 13.7 
Schake(l 8) Chemstrip BG® 22 0.95 NR* NR 
Clements(9) Dextrostix® 41 
» 
0.952 NR ** 10.7 
Eye Tone® 41 0.966 NR ** 10.7 
Alexander (2 ) Chemstrip BGP 143* 0.942 NR NR 
Shapiro(19) Chemstrip BG® 125 0.935 NR 17.8 
Chernow (8 ) Chemstrip BG® 133 0.96 NR NR 
Strickland(24) Glucometer® 171 0.981 NR NR 
Eye Tone® 171* 0.968 NR NR 
Vanden(4 ) Chemstrip BG® 23 NR 20 NR 
Stat Tek® 23 NR 15 NR 
Fairclough(ll ) Chemstrip BG® 33 0.96 NR 10.7 
Perelman (16 ) Chemstrip BG® 90 0.798 26.2 NR 
Frindik(12 ) Chemstrip BG® 99 0.84 12.4 
Silverstein (20) Chemstrip BG® 159 0.976 NR * * 26 
Aziz (3) Accu-Chek® ) 115 0.842 
Godine(6 ) Accu-Chek® 163 0.96 NR 7.9 
Cunningham Accu-Chek® 
(cap) 
50 0.99 11.5 12.3 
Cunningham Accu-Chek® 
(ven) 
) 50 0.91 15.6 17.1 
Not reported 
* * 
Percentage of determinations that varied by greater than 20% from 
the true or reference value 




















1 282 260 251 7.8 11 .0 3.5 
2 252 240 234 4 .8 7.1 2.5 
3 248 241 236 2.8 4.8 2.1 
4 242 230 224 5.0 7.4 2.6 
5 242 230 241 5.0 0.4 4.8 
6 238 231 226 2.9 5.0 2.2 
7 236 224 234 5.1 » 0.8 4.5 
8 166 158 175 4.8 5.4X 10.8 
. 9 160 150 165 6.3 3.1 10.0 
10 156 146 161 6.4 3.2 10. 3 
11 156 148 165 5.1 5.8 11.5 







Capillary Accu-Chek® Venous vs. 
Accu-Chek® Capillary 
Average 10.8 10 .6 10.8 
Variance 16.2 72 .3 22.4 
Standard Deviation 4-0 8 .5 4.7 
Range 15.0 30 .0 12.0 (continued) 
Table 4• (continued) 
Percent Accu-Chek® Venous Accu-Chek® Capillary Accu-Chek® Venous vs. 
Error vs. Lab vs. Lab Accu-Chek® Capillary 
Average 5.3 4.8 6.4 
Variance 2.2 8.6 16.4 
Standard Deviation 1.5 2.9 4.0 
Range 5.0 10.1 9.4 
Glucose concentration (mg/dl) 
Table 5. Patient Data with Glucose Concentrations Between 125 mg/dl and 80 mg/dl 
Accu-Chek® Accu-Chek® Lab vs. Lab vs. Accu-Chek® 
Sample Laboratory Venous Capillary Accu-Chek® Accu-Chek® Venous vs 
Number Value* Value* Value* Ven.% Diff Cap.% Diff Cap.% Diff 
13 122 149 131 22 .1 7.4 12. 1 
14 119 132 131 10.9 10.1 1.0 
15 110 102 124 7.3 12.7 21.6 
16 106 116 111 9.4 4.7 4.3 
17 104 141 101 35.6 2.9 28.4 
18 103 130 112 26.2 8.7 13.8 
19 102 112 122 9.8 19.6 8.9 
20 102 112 110 9.8 7.8 1.8 
21 100 113 118 13.0 18.0 4.4 
22 100 113 112 13.0 12.0 1.0 
23 96 99 97 • 3.1 • 1.0 2.0 
24 96 109 110 13.5 14.6 1.0 
25 91 83 105 8.8 15.4 26.5 
26 87 97 92 11.5 5.7 5.2 
27 87 97 95 11.5 9.2 2.1 
28 87 94 105 8.0 20.7 11.7 
29 86 111 93 29.1 8.1 16.2 
30 85 93 100 9.4 17.6 7.5 
31 85 97 99 14.1 16.5 2.1 
32 83 93 103 12.0 24.1 10.8 
33 81 103 92 27.2 13.6 10.7 
34 81 94 99 16.0* 22.2 5.3 
35 81 101 98 24.7 21 .0 2.9 
36 80 93 94 16 .3 17.5 1.1 
(continued) 
Table (continued) 
Error Accu-Chek® Venous Accu-Chek® Capillary Accu-Chek® Venous vs. 
mg/dl vs. Lab vs. Lab Accu-Chek® Capillary 
Average 14.3 11.9 9.3 
Variance 63.9 28.9 91.6 
Standard Deviation 7.9 5.4 9.6 

























Glucose concentration (mg/dl) 





















37 79 100 84 26.6 6 .3 16 -0 
38 87 104 96 19 .5 10-3 7 -7 
39 77 90 91 16 -9 18-2 1.1 
40 75 82 93 9.3 24.0 13-4 
41 75 91 85 21.3 13.3 6.6 
42 75 81 78 8.0 4.0 3.7 
43 74 99 81 33.8 9.4 18.2 
44 72 100 74 38.8 2.8 26.0 
45 72 105 100 45.8 • 38.9 . 4.8 
46 72 94 85 30.6 18.1 9.6 
47 70 94 72 34.3 2.9 23.4 
48 65 95 91 46.2 40.0 4.2 
49 60 88 62 46.7 3.3 29.5 






















































Glucose concentration (mg/dl) 
K> OJ 











-Chek® Venous vs. 
-Chek® Capillary 
Average 15.4 11.5 10.5 
Variance 51 .4 58 .7 66 .5 
Standard Deviation 7 .2 3.6 8.2 













-Chek® Venous vs. 
-Chek® Capillary 
Average 17.0. 11.5 9.0 
Variance 81 .1 37.9 
4 
56 .9 
Standard Deviation 9.0 6.2 7.5 
Range 43.5 39.6 29.4 
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Table 8. Cost Analysis 
A. Clinical Laboratory 
Blood Glucose 
Stat Fee 






B. Accu-Chek® Capital Items3 Over One Year 
Instrument *v • • $ 0.42/day 
Auto clix® 0.02/day 
1. One Time Charges 
Item Charge 
Lancets . . . . . . . . . $ 0.07/each 
Alcohol Wipes 0.02/each 
Cotton Balls 0.01/each 
Chemstrip BG * . . . 0.45/each 
2. Employee Charge^ 
Pharmacist $ 1.52/seven 
minutes 
3. Calculated Costs for Accu-Chek® System 
Draws per Day 
One daily draw . . . . . . 
Five daily draws 





Based on retail price of $150 for the Accu—Chek and $7 for the 
Auto-clix® 
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A COMPARISON OF TWO BLOOD GLUCOSE MONITORING METHODS FOR 
ACCURACY AND COST-EFFECTIVENESS IN THE HOSPITAL SETTING 
Informed Consent Form 
You are invited to participate in a study to determine whether a 
small portable instrument (Accu-Chek) that measures the amount of sugar 
in the blood is an accurate and cost-effective alternative to measuring 
blood sugar by the hospital laboratory. Monitoring blood sugar is 
important in the ill, diabetic, and'^in patients receiving intravercus 
fluids. This study will examine venous blood, one milliliter (15 
drops) , obtained at the same time as blood obtained by the hospital 
laboratory. Therefore, no extra venous punctures will be necessary. 
Immediately after obtaining the venous sample, the participant will 
undergo a finger puncture, accomplished by a automatic device that 
punctures the end of the finger. Two to four drops of blood will be 
collected for the Accu-Chek glucose determination. These two blood 
samples (venous and finger puncture) will be compared to the blood sugar 
concentration measured by the hospital laboratory. 
The possible risks of the finger puncture includes mild localized 
pain, infection, and slight bleeding. The possible future benefits of 
the Accu-Chek system would include; decrease in the number of venous 
punctures, quicker glucose determinations, and a decrease in patient 
cost. 
Patient confidentiality will be maintained at all times. If the 
participant ever has any questions concerning the study, he/she may call 
Patrick Cunningham at 485-8875 or Dr. Frank Tyler at 581-2121. Patient 
participation in this study is voluntary and the participant at any time 
may decline to continue the study without any consequences. 
Participant Signature Date 
Guardian Signature (if patient is under 
18 years of age) 
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